Feb 23, 2022 | Press Releases
CINCINNATI, Feb. 23, 2022 — Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing vaccines, today announced the closing of its initial public offering of 2,222,222...
Feb 23, 2022 | Press Releases
CINCINNATI, Feb. 23, 2022 — Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing vaccines, today announced the closing of its initial public offering of 2,222,222...
Feb 17, 2022 | Press Releases
CINCINNATI, Feb. 17, 2022 — Blue Water Vaccines, Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing vaccines, today announced the pricing of its initial public offering of 2,222,222...
Feb 17, 2022 | Press Releases
CINCINNATI, Feb. 17, 2022 — Blue Water Vaccines, Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing vaccines, today announced the pricing of its initial public offering of 2,222,222...
